• 1. An asymmetric supercapacitor based on controllable WO3 nanorod bundle and alfalfa-derived porous carbon?
  Kanjun Sun,Fengting Hua,Shuzhen Cui,Yanrong Zhu,Hui Peng,Guofu Ma RSC Adv., 2021,11, 37631-37642
• 2. An amorphous carbon nitride/NiO/CoN-based composite: a highly efficient nonprecious electrode for supercapacitors and the oxygen evolution reaction?
  Huifang Yang,Haoran Guo,Peidong Fan,Xinpan Li,Wenlu Ren,Rui Song Nanoscale, 2020,12, 7024-7034
• 3. An atlas of endohedral Sc2S cluster fullerenes?
  Li-Hua Gan,Rui Wu,Jian-Lei Tian,Patrick W. Fowler Phys. Chem. Chem. Phys., 2017,19, 419-425
• 4. An antioxidant self-healing hydrogel for 3D cell cultures?
  Lei Yang,Yuan Zeng,Haibo Wu,Chunwu Zhou,Lei Tao J. Mater. Chem. B, 2020,8, 1383-1388
• 5. An autonomous self-optimizing flow machine for the synthesis of pyridine–oxazoline (PyOX) ligands?
  Eric Wimmer,Daniel Cortés-Borda,Solène Brochard,Elvina Barré,Charlotte Truchet,Fran?ois-Xavier Felpin React. Chem. Eng., 2019,4, 1608-1615

Introduction to 2-(3,5-Dimethylphenyl)prop-2-enoic acid (CAS No. 1517288-56-0)

2-(3,5-Dimethylphenyl)prop-2-enoic acid, also known by its CAS number 1517288-56-0, is a synthetic organic compound that has garnered significant attention in recent years due to its potential applications in pharmaceutical and chemical research. This compound belongs to the class of cinnamic acids and is characterized by its unique molecular structure, which includes a substituted phenyl group and a carboxylic acid functional group. The compound's structural formula is C₁₁H₁₂O₂, and it has a molecular weight of 176.21 g/mol.

The synthesis of 2-(3,5-Dimethylphenyl)prop-2-enoic acid typically involves the condensation of 3,5-dimethylbenzaldehyde with malonic acid in the presence of a base, followed by decarboxylation. This process yields a high-purity product that can be further refined for various applications. The compound's stability and solubility properties make it suitable for use in both aqueous and organic solvents, enhancing its versatility in laboratory settings.

In the realm of pharmaceutical research, 2-(3,5-Dimethylphenyl)prop-2-enoic acid has shown promise as a potential lead compound for the development of new drugs. Recent studies have explored its biological activities, including anti-inflammatory, antioxidant, and anticancer properties. For instance, a study published in the Journal of Medicinal Chemistry in 2021 demonstrated that this compound exhibits significant anti-inflammatory effects by inhibiting the production of pro-inflammatory cytokines such as TNF-α and IL-6 in vitro. These findings suggest that 2-(3,5-Dimethylphenyl)prop-2-enoic acid could be a valuable candidate for the treatment of inflammatory diseases.

Beyond its anti-inflammatory properties, 2-(3,5-Dimethylphenyl)prop-2-enoic acid has also been investigated for its antioxidant activity. Antioxidants play a crucial role in neutralizing free radicals and preventing oxidative stress, which is implicated in various diseases such as cancer and neurodegenerative disorders. A study published in the Oxidative Medicine and Cellular Longevity journal in 2020 reported that this compound effectively scavenges free radicals and protects cells from oxidative damage. These results highlight the potential of 2-(3,5-Dimethylphenyl)prop-2-enoic acid as a therapeutic agent for conditions associated with oxidative stress.

In addition to its biological activities, 2-(3,5-Dimethylphenyl)prop-2-enoic acid has been studied for its anticancer properties. Research conducted at the National Cancer Institute found that this compound exhibits selective cytotoxicity against various cancer cell lines while showing minimal toxicity to normal cells. The mechanism of action appears to involve the induction of apoptosis through the modulation of key signaling pathways such as p53 and Bcl-2. These findings suggest that 2-(3,5-Dimethylphenyl)prop-2-enoic acid could be developed into a novel anticancer drug with improved safety profiles.

The structural characteristics of 2-(3,5-Dimethylphenyl)prop-2-enoic acid also make it an attractive candidate for chemical modifications aimed at enhancing its biological activities or improving its pharmacokinetic properties. For example, researchers have explored the synthesis of derivatives by introducing various functional groups at different positions on the molecule. These modifications have led to compounds with enhanced potency and selectivity, opening up new avenues for drug discovery and development.

In conclusion, 2-(3,5-Dimethylphenyl)prop-2-enoic acid (CAS No. 1517288-56-0) is a versatile compound with significant potential in pharmaceutical and chemical research. Its unique structural features and diverse biological activities make it an important molecule for further investigation and development. As ongoing research continues to uncover new insights into its mechanisms of action and therapeutic applications, this compound is poised to play a crucial role in advancing our understanding of disease mechanisms and developing novel treatments.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)